Speaking of A-shares, I am very optimistic about the trend of the next decade, because A large number of institutional investors enter the market, the demand for high-quality assets is becoming more and more obvious, so A good track is the key to win steadily.
In the past 20 years, the Internet is undoubtedly the most powerful outlet for A-shares. Even without giants like BAT, there is still no shortage of 10x and 20x big stocks. With the adjustment of China's industrial structure and the development of science and technology in human society, biopharmaceuticals will undoubtedly become the most powerful voice in the next 10 years. From the COVID-19 outbreak in 2019, we can already see that the biopharmaceutical industry has received financial attention, as well as market prospects.
As can be seen from the chart, after four years of bear market, the index has completed the adjustment of ABC and entered a new rising cycle in 2019. Due to the lack of historical data before 2012, we cannot confirm which band is running here. But regardless of the band, this wave will be very hot, and even on 2019's path, the chance of a future index doubling is very easy to come by.
So for those who lack the conditions for fundamental research, they might as well choose a biopharmaceutical theme fund and hold it for the long term, believing that the future will have a rich return.